• COVID-19 has impacted headache and neurological care in New York in a variety of ways, including a shift in staffing, educational strategies, and an abrupt transformation to telemedicine.
• A number of primary and secondary headache disorders may be encountered in association with COVID-19.
• Migraine may be triggered by COVID-19 either directly or indirectly, related to biological or psychological mechanisms.
• Clinicians face a number of therapy challenges such as patient fear to frequent hospitals and concerns regarding the use of migraine medicine.